BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, July 9, 2026
Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

Tryton pushes forward with pivotal stent trial; completes enrollment

Nov. 27, 2012
By Omar Ford

Exact Sciences completes: enrollment for Deep-C trial

Nov. 20, 2012
By Omar Ford

Corus CAD gene expression test effective in elderly population

Nov. 19, 2012
By Omar Ford

Guided Therapeutics submits amended PMA for LuViva

Nov. 15, 2012
By Omar Ford

FI's powered artificial limb could pave way for neuroprosthetics

Nov. 12, 2012
By Omar Ford

NewCo on the Go: SpinalCyte uses cells instead of implants to treat degenerative disc

Nov. 9, 2012
By Omar Ford

Siemens launches application to help deal with hospital anxiety

Nov. 8, 2012
By Omar Ford

2012 Medical Innovation Summit: From implants to diagnostics, Zimmer's Dvorak discusses all

Nov. 7, 2012
By Omar Ford
CLEVELAND — Knee implants can be a tricky thing. On one hand, even though they can be done successfully – patients sometimes have significant concerns of how the implant feels. Last week, David Dvorak, Zimmer's (Warsaw, Indiana) CEO spoke to a crowded room at Cleveland Clinic's 2012 Medical Innovation Summit about this topic and several others during one of the final CEO one-on-ones of the conference.
Read More
Cc symbol only12

Rethinking Innovation

Nov. 5, 2012
By Omar Ford
If I had to sum up the key take away from Cleveland Clinic's Medical Innovation Summit last week, I would probably say something like this : Innovation is alive and well, but are hospitals and physicians willing to pay for it when capital is so strained? Nearly every panel that I attended seemed to have that as an underlying theme. Everyone from Cleveland Clinic's own Dr. Joseph Iannotti to Medtronic's CEO Omar Ishrak made statements about innovation in healthcare and the importance of having it present in an environment where capital is limited and dollars are few. Iannotti made...
Read More

2012 Medical Innovation Summit: Imaging Modalities continue to shape ortho-procedures

Nov. 5, 2012
By Omar Ford
CLEVELAND — There is no question that new imaging modalities have made a tremendous impact on current orthopedic procedures. During the closing day of Cleveland Clinic's 2012 Medical Innovation Summit, a panel talked about this impact as well as the integration of diagnostics and therapeutics in a session called New Imaging Modalities shaping Orthopedics.
Read More
View All Articles by Omar Ford

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 8, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • Myelin sheath and neurons in the brain

    GDE4 blockade promotes remyelination, study finds

    BioWorld Science
    Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing